SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    The Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol. 2000; 19: 509518.
  • 2
    Prados MD, Scott C, Curran WJ, et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol. 1999; 17: 33893395.
  • 3
    Westphal M, Hilt DC, Bortey E, et al. A Phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncology. 2003; 5: 7988.
  • 4
    Grossman SA, O'Neill A, Grunnet M, et al. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol. 2003; 21: 14851491.
  • 5
    Prados MD, Levin V. Biology and treatment of malignant glioma. Semin Oncol. 2000; 27 (Suppl 3): 110.
  • 6
    Gutin PH, Prados MD, Phillips TL, et al. External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas: NCOG Study 6G82-2. Int J Radiat Oncol Biol Phys. 1991; 21: 601606.
  • 7
    Kornblith PD, Welch WC, Bradley MK. The future of therapy for glioblastoma. Surg Neurol. 1993; 39: 538543.
  • 8
    Loeffler JS, Alexander E, Shea WM, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol. 1992; 10: 13791385.
  • 9
    Prados MD, Gutin PH, Phillips TL, et al. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys. 1992; 24: 593597.
  • 10
    Levin VA, Silver P, Hannigan J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys. 1990; 18: 321324.
  • 11
    Stewart LA. Chemotherapy in adult high-grade glioma: a systemic review and meta-analysis of individual patient data from 12 randomized trials. Lancet. 2002; 359: 10111018.
  • 12
    Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiation therapy and without chemotherapy for malignant gliomas in adults. Cancer. 1993; 71: 25852597.
  • 13
    Wong ET, Hess KR, Gleason MJ, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto Phase II clinical trials. J Clin Oncol. 1999; 17: 25722578.
  • 14
    Yung WK, Mechtler L, Gleason MJ. Intravenous carboplatin for recurrent malignant gliomas: a Phase II study. J Clin Oncol. 1991; 9: 860864.
  • 15
    Allen JC, Bloom HJ, Ertel I, et al. Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Semin Oncol. 1986; 13: 110122.
  • 16
    Allen JC, Helson L. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg. 1981; 55: 749756.
  • 17
    Longee DC, Friedman HS, Albright RE, et al. Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg. 1990; 72: 583588.
  • 18
    MacDonald DR, Cascino TL, Schold SC, et al. Response criteria for Phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990; 8: 12771280.
  • 19
    Jaeckle KA, Hess KR, Yung A, et al. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol. 2003; 21: 23052311.
  • 20
    Yung WK, Kyritsis AP, Gleason MJ, et al. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Clin Cancer Res. 1996; 2: 19311935.
  • 21
    Fine HA, Wen PY, Maher EA, et al. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. J Clin Oncol. 2003; 21: 22992304.
  • 22
    Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neurooncology. 1999; 1: 152161.
  • 23
    Fetell MR, Grossman SA, Balmaceda C. Clinical and pharmacologic study of preirradiation Taxol administrated as a 96-hour infusion in adults with newly diagnosed glioblastoma multiforme [abstract]. Proc Am Soc Clin Oncol. 1994; 13: 179.